Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

34

Revenue 2017

Tivicay

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tivicay was produced by AbbVie and Eisai.

ViiV bags EU okay for new two-drug HIV therapy

ViiV bags EU okay for new two-drug HIV therapy

Dovato – a fixed-dose combination of ViiV’s blockbuster integrase inhibitor Tivicay (dolutegravir) and the nucleoside reverse transcriptase inhibitor lamivudine – is integral to the company’s attempt to muscle out

Shingrix lifts GSK in Q1, but two more vaccines are culled

Shingrix lifts GSK in Q1, but two more vaccines are culled The bulk of GSK’s HIV sales come from its dolutegravir-based combination products Tivicay and Triumeq, but greater competition in the market from arch-rival Gilead Sciences with new products ... That was particularly apparent for three-drug combo

Dovato approval key for Glaxo in HIV treatment

Dovato approval key for Glaxo in HIV treatment If the cost of prescribing Tivicay (dolutegravir) plus generic lamivudine is substantially lower than the cost of Dovato, it’s possible clinicians and payers could consider this approach.”.

Gilead awaits CEO and readouts to revive fortunes

Gilead awaits CEO and readouts to revive fortunes It earned $551m in the fourth quarter and picked up both treatment-naïve patients and those switching from other drugs, including GSK’s rival drug Tivicay and its own established product

GSK’s says depot HIV injection works over three years

GSK’s says depot HIV injection works over three years Earlier this year,   GSK won approval for oral two-drug regimen Juluca – based on integrase inhibitor Tivicay (dolutegravir) and rilpivirine – that aims to provide effective control of HIV with a single

1 2 3 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics